Minimizing Skin Scarring through Biomaterial Design
Source abstract
Abstract
Wound healing continues to be a major burden to patients, though research in the field has expanded significantly. Due to an aging population and increasing comorbid conditions, the cost of chronic wounds is expected to increase for patients and the U.S. healthcare system alike. With this knowledge, the number of engineered products to facilitate wound healing has also increased dramatically, with some already in clinical use. In this review, the major biomaterials used to facilitate skin wound healing will be examined, with particular attention allocated to the science behind their development. Experimental therapies will also be evaluated.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of General and Gastrointestinal Surgery, Brigham and Women’s Hospital, Boston, MA 02115, USA
Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
Institute of Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA
Funding
Society of University Surgeons Resident Scholar Award · Tissue and Transplant Engineering Center of Excellence Fellowship
References (100+)
Show source-provided references
1. Human skin wounds: A major and snowballing threat to public health and the economy10.1111/j.1524-475X.2009.00543.x ↗
2. Cutaneous wound healing10.1056/NEJM199909023411006 ↗
3. Topical silicone gel for the prevention and treatment of hypertrophic scar10.1001/archsurg.1991.01410280103016 ↗
4. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars
5. Henshaw, F.R., Boughton, P., Lo, L., McLennan, S.V., and Twigg, S.M. (2015). Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: Potential role for CTGF in human diabetic foot ulcer healing. J. Diabetes Res., 2015.10.1155/2015/236238 ↗
6. Hyaluronan induces scarless repair in mouse limb organ culture10.1016/S0022-3468(98)90317-7 ↗
7. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: Implications for wound healing10.1073/pnas.85.13.4894 ↗
8. Avotermin for scar improvement following scar revision surgery: A randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial10.1097/PRS.0b013e318217429b ↗
9. Science of Hyaluronic Acid Beyond Filling: Fibroblasts and Their Response to the Extracellular Matrix10.1097/PRS.0000000000001823 ↗
10. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial10.1016/j.jvs.2005.01.042 ↗
11. Scarless fetal healing. Therapeutic implications10.1097/00000658-199201000-00004 ↗
12. Growth factors and cytokines in wound healing10.1111/j.1524-475X.2008.00410.x ↗
13. Fetal skin wound healing10.1016/S0065-2423(09)48006-5 ↗
14. Fibrin-based stem cell containing scaffold improves the dynamics of burn wound healing10.1111/wrr.12459 ↗
15. HIF-1 as a target for drug development10.1038/nrd1199 ↗
16. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing10.1046/j.1523-1747.1999.00600.x ↗
17. Animal models for the study of fetal tissue repair10.1016/0022-4804(91)90097-6 ↗
18. Wound Healing: Part I. Basic Science10.1097/PRS.0000000000002773 ↗
19. Biology and Biomarkers for Wound Healing10.1097/PRS.0000000000002682 ↗
20. Ghatak, S., Maytin, E.V., Mack, J.A., Hascall, V.C., Atanelishvili, I., Moreno Rodriguez, R., Markwald, R.R., and Misra, S. (2015). Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis. Int. J. Cell Biol., 2015.10.1155/2015/834893 ↗
21. Extracellular matrix alters PDGF regulation of fibroblast integrins10.1083/jcb.132.1.239 ↗
22. Metalloproteinase inhibitors and wound healing: A novel enhancer of wound strength10.1016/S0039-6060(98)70154-0 ↗
23. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers10.1006/jsre.1998.5495 ↗
24. Neutralisation of TGF-beta 1 and TGF-β 2 or exogenous addition of TGF-β 3 to cutaneous rat wounds reduces scarring10.1242/jcs.108.3.985 ↗
25. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing10.1074/jbc.271.17.10188 ↗
26. Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: Time for a moratorium?10.1080/14653240902849788 ↗
27. Garcia-Orue, I., Gainza, G., Gutierrez, F.B., Aguirre, J.J., Evora, C., Pedraz, J.L., Hernandez, R.M., Delgado, A., and Igartua, M. (2016). Novel nanofibrous dressings containing rhegf and aloe vera for wound healing applications. Int. J. Pharm., in press.10.1016/j.ijpharm.2016.11.006 ↗
28. Tissue engineering and regenerative repair in wound healing10.1007/s10439-014-1010-z ↗
29. Khan, S., Villalobos, M.A., Choron, R.L., Chang, S., Brown, S.A., Carpenter, J.P., Tulenko, T.N., and Zhang, P. (2016). Fibroblast growth factor and vascular endothelial growth factor play a critical role in endotheliogenesis from human adipose-derived stem cells. J. Vasc. Surg.10.1016/j.jvs.2016.04.034 ↗
30. Li, Y., Jalili, R.B., and Ghahary, A. (2016). Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites. Sci. Rep., 6.10.1038/srep28979 ↗
31. Mandapalli, P.K., Labala, S., Jose, A., Bhatnagar, S., Janupally, R., Sriram, D., and Venuganti, V.V. (2016). Layer-by-Layer Thin Films for Co-Delivery of TGF-beta siRNA and Epidermal Growth Factor to Improve Excisional Wound Healing. AAPS PharmSciTech.10.1208/s12249-016-0571-6 ↗
32. Nitric oxide and wound healing10.1007/s00268-003-7396-7 ↗
33. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers10.1016/0140-6736(92)90143-Q ↗
34. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group10.1016/S0741-5214(95)70245-8 ↗
35. Healthy human second-trimester fetal skin is deficient in leukocytes and associated homing chemokines10.1111/wrr.12421 ↗
36. A bioengineered drug-Eluting scaffold accelerated cutaneous wound healing In diabetic mice10.1016/j.colsurfb.2016.04.056 ↗
37. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum
38. The role of macrophage phenotype in vascularization of tissue engineering scaffolds10.1016/j.biomaterials.2014.02.012 ↗
39. Vunjak-Novakovic, Macrophages modulate engineered human tissues for enhanced vascularization and healing10.1007/s10439-014-1156-8 ↗
40. Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing10.1089/wound.2012.0407 ↗
41. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR410.1007/s00109-014-1123-8 ↗
42. Processing of CXCL12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing10.1111/febs.13043 ↗
43. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair10.1016/j.jss.2013.01.019 ↗
44. Stromal cell-derived factor-1 (SDF-1): Homing factor for engineered regenerative medicine10.1517/14712598.2011.546338 ↗
45. Hosono, K., Isonaka, R., Kawakami, T., Narumiya, S., and Majima, M. (2016). Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice. PLoS ONE, 11.10.1371/journal.pone.0162532 ↗
46. Methods for Implant Acceptance and Wound Healing: Material Selection and Implant Location Modulate Macrophage and Fibroblast Phenotypes10.1002/adhm.201600532 ↗
47. Wound healing: An update10.2217/rme.14.54 ↗
48. Understanding fibroblast heterogeneity in the skin10.1016/j.tcb.2014.10.001 ↗
49. Distinct fibroblast lineages determine dermal architecture in skin development and repair10.1038/nature12783 ↗
50. Fgf9 from dermal gammadelta T cells induces hair follicle neogenesis after wounding10.1038/nm.3181 ↗
51. Rinkevich, Y., Walmsley, G.G., Hu, M.S., Maan, Z.N., Newman, A.M., Drukker, M., Januszyk, M., Krampitz, G.W., Gurtner, G.C., and Lorenz, H.P. (2015). Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science, 348.10.1126/science.aaa2151 ↗
52. Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor10.1096/fj.00-0772fje ↗
53. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids10.1097/01.PRS.0000056868.42679.05 ↗
54. Intralesional Cryotherapy versus Excision with Corticosteroids or Brachytherapy for Keloid Treatment: Preliminary Results of a Randomized Controlled Trial10.1097/01.prs.0000472473.17120.4a ↗
55. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine10.1002/jcp.21200 ↗
56. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro10.1073/pnas.83.12.4167 ↗
57. Scarless wound healing: Finding the right cells and signals10.1007/s00441-016-2424-8 ↗
58. Wound healing and inflammation: Embryos reveal the way to perfect repair10.1098/rstb.2004.1466 ↗
59. Wound healing in oral mucosa results in reduced scar formation as compared with skin: Evidence from the red Duroc pig model and humans10.1111/j.1524-475X.2009.00531.x ↗
60. Tredget, Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing10.3390/jfb6030547 ↗
61. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis10.1097/00007890-199507150-00001 ↗
62. The use of acellular, fetal bovine dermal matrix for acute, full-thickness wounds
63. The use of collagen-based matrices in the treatment of full-thickness wounds10.1016/j.burns.2016.03.017 ↗
64. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns10.1016/0305-4179(95)93866-I ↗
65. Current Concepts in Tissue Engineering: Skin and Wound10.1097/PRS.0000000000002685 ↗
66. Stem Cell-Based Therapeutics to Improve Wound Healing
67. Effect of collagen matrices on dermal wound healing10.1016/j.addr.2003.08.003 ↗
68. Designed three-dimensional collagen scaffolds for skin tissue regeneration10.1089/ten.tec.2009.0511 ↗
69. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering10.1016/S0142-9612(03)00374-0 ↗
70. Design principles for composition and performance of cultured skin substitutes10.1016/S0305-4179(01)00019-5 ↗
71. Frequent Application of the New Gelatin-Collagen Nonwoven Accelerates Wound Healing10.1097/01.ASW.0000476097.86161.57 ↗
72. Assessment of replication rates of human keratinocytes in engineered skin substitutes grafted to athymic mice10.1111/j.1524-475X.2012.00807.x ↗
73. A systematic review and meta-analysis of the topical administration of fibrin sealant in total hip and knee arthroplasty10.1016/j.ijsu.2016.10.022 ↗
74. A comparative study of skin cell activities in collagen and fibrin constructs10.1016/j.medengphy.2016.05.017 ↗
75. Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury10.1002/jbm.a.32343 ↗
76. Miron, R.J., Fujioka-Kobayashi, M., Bishara, M., Zhang, Y., Hernandez, M., and Choukroun, J. (2016). Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review. Tissue Eng. Part B Rev.10.1089/ten.teb.2016.0233 ↗
77. Litvinov, R.I., and Weisel, J.W. (2016). Fibrin mechanical properties and their structural origins. Matrix Biol., in press.
78. Hyaluronic Acid in Inflammation and Tissue Regeneration
79. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study10.1111/wrr.12428 ↗
80. Use of Platelet Rich Plasma and Hyaluronic Acid in the Treatment of Complications of Achilles Tendon Reconstruction
81. Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis10.1016/j.pharep.2016.07.001 ↗
82. Albeiroti, S., Soroosh, A., and de la Motte, C.A. (2015). Hyaluronan’s Role in Fibrosis: A Pathogenic Factor or a Passive Player?. BioMed Res. Int., 2015.10.1155/2015/790203 ↗
83. Philibert, T., Lee, B.H., and Fabien, N. (2016). Current Status and New Perspectives on Chitin and Chitosan as Functional Biopolymers. Appl. Biochem. Biotechnol.10.1007/s12010-016-2286-2 ↗
84. Dual Drug-Loaded Biofunctionalized Amphiphilic Chitosan Nanoparticles: Enhanced Synergy between Cisplatin and Demethoxycurcumin against Multidrug-Resistant Stem-Like Lung Cancer Cells10.1016/j.ejpb.2016.10.014 ↗
85. Muanprasat, C., and Chatsudthipong, V. (2016). Chitosan oligosaccharide: Biological activities and potential therapeutic applications. Pharmacol. Ther.10.1016/j.pharmthera.2016.10.013 ↗
86. Siy, R.W., Pferdehirt, R.E., and Izaddoost, S.A. (2016). Non-crosslinked porcine acellular dermal matrix in pediatric abdominal wall reconstruction: A case series. J. Pediatr. Surg.10.1016/j.jpedsurg.2016.09.057 ↗
87. Plastic Surgery and Acellular Dermal Matrix: Highlighting Trends from 1999 to 2013
88. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers
89. Porcine Acellular Dermal Matrix for Hernia Repair in Transplant Patients10.1097/SAP.0000000000000929 ↗
90. Surgeon-Controlled Study and Meta-Analysis Comparing FlexHD and AlloDerm in Immediate Breast Reconstruction Outcomes10.1097/PRS.0000000000002616 ↗
91. Acellular dermal matrix in the management of the burn patient10.1177/1090820X11418202 ↗
92. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes10.1016/S0002-9610(02)00813-9 ↗
93. Prospective randomized comparison of scar appearances between cograft of acellular dermal matrix with autologous split-thickness skin and autologous split-thickness skin graft alone for full-thickness skin defects of the extremities10.1097/PRS.0000000000001204 ↗
94. Pilot trial of biovance collagen-based wound covering for diabetic ulcers10.1097/01.ASW.0000305463.32800.32 ↗
95. Beware of the commercialization of human cells and tissues: Situation in the European Union10.1007/s10561-012-9323-3 ↗
96. Comparison of Antibiotic-Coated versus Uncoated Porcine Dermal Matrix10.1097/PRS.0000000000002688 ↗
97. Do Processing Methods Make a Difference in Acellular Dermal Matrix Properties?10.1093/asj/sjw163 ↗
98. The Role of Stem Cell Therapeutics in Wound Healing: Current Understanding and Future Directions10.1097/PRS.0000000000002646 ↗
99. Poly(ethylene glycol)-Based Hyperbranched Polymer from RAFT and Its Application as a Silver-Sulfadiazine-Loaded Antibacterial Hydrogel in Wound Care10.1021/acsami.6b11371 ↗
100. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis10.1016/j.biomaterials.2004.01.066 ↗